On ECHEMI
Home > Drugs > Jaw cancer
Jaw cancer
Cancer is the most common malignant tumor in the oral and maxillofacial region, and squamous cell carcinoma is the most common cancer. In my country, oral and maxillofacial squamous cell carcinoma mostly occurs between the ages of 40 and 60, and is more common in men than in women. Gingival cancer, tongue cancer, cheek cancer, palate cancer and maxillary sinus cancer are common, while jaw cancer is relatively rare. Oral cancer accounts for 1.45-5.6% of all malignant tumors in the north of the Yangtze River in my country, and 1.75-5.18% in the south of the Yangtze River. In India, it accounts for more than 40% of all malignant tumors in the body. Jaw cancer mainly occurs in the remaining cells of the enamel epithelium of the tooth germ. These epithelial cells can remain in the periodontal ligament, cyst lining, and from the malignant transformation of ameloblastoma. In terms of histological type, it can be either squamous cell carcinoma or glandular epithelial carcinoma.
  • Site of disease:

    mouth
  • Infectious :

    Not contagious
  • Frequent population:

    Adults
  • Related symptoms:

    Toothache Loose and falling teeth Numbness of lower lip Jaw protrusion deformity Toothache
  • Concurrent disease:

Related Drugs
Thymopentin injection
Indication: For chronic hepatitis B patients over 18 years old. Because the thymus begins to atrophy after 18 years old, the cellular immune function is reduced. 2 Various primary or secondary T cell deficiency diseases. 3 Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus, etc.). 4 Various diseases with low cellular immune function. 5 Adjuvant treatment of tumors.
Manufacturer:

Hainan Zhonghe Pharmaceutical Co., Ltd.

WeiDaKang Granules
Manufacturer:

Harbin Oriental Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.